News
- Kindred Biosciences Announces Half-Life Extension Technology for Canine AntibodiesJanuary 8, 2020 4:02 PM EST
- Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in DogsDecember 16, 2019 8:02 AM EST
- Kindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight LossDecember 12, 2019 9:05 AM EST
Events
- Wednesday, January 8, 2020 4:30 PM EST
- Thursday, November 21, 2019
- Tuesday, November 19, 2019 from 10:20 AM to 10:50 AM EST
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Events & Presentations